Advertisements



We are Sorry, This Page doesn't Exist


Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost

Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost.....»»

Category: topSource: seekingalphaApr 9th, 2018

Brainstorm Health: Facebook Hospital Data, Incyte Stock, Yescarta Price

Brainstorm Health Daily: April 6, 2018 Hello and happy Friday, readers! This is Sy. Shares of biotech Incyte tumbled following a clinical trial setback for one of the company’s marquee experimental cancer.....»»

Category: europeSource: fortuneApr 6th, 2018

Cellectar Biosciences Strong Preliminary Data For Rare Cancer Treatment Is Encouraging

Cellectar Biosciences Strong Preliminary Data For Rare Cancer Treatment Is Encouraging.....»»

Category: topSource: seekingalphaJul 18th, 2018

Here"s Why Novocure Ltd. Rose 55% in the First Half of 2018

What happened Shares of Novocure Ltd NASDAQ NVCR a company treating brain cancer with electric fields rose 55 in the first half of the year according to data from S amp P Global Market Intelligence The odd looking Optune device got off to a slow start but.....»»

Category: futuresSource: nasdaqJul 14th, 2018

Advaxis shares rise 68% after FDA lifts clinical hold on its drug trial

Shares of the biotech company Advaxis Inc. surged 68% in premarket trade on Friday after the Food and Drug Administration lifted a clinical hold on the company's phase 1/2 study for a cancer drug combination. The clinical hol.....»»

Category: topSource: marketwatchJul 13th, 2018

VBL says data shows MOSPD2 can play major role in breast cancer cell migration

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2018

Biotech Analysis Central Pharma News: Catabasis Nears Phase 3 Start, Regulus Slashes Workforce, Cytori"s Mixed ED Data

Biotech Analysis Central Pharma News: Catabasis Nears Phase 3 Start, Regulus Slashes Workforce, Cytori"s Mixed ED Data.....»»

Category: topSource: seekingalphaJul 10th, 2018

Biotech ETFs Surge on Biogen"s Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment. Biogen Inc. BIIB was a star performer in Friday’s trading session, as the stock rallied as much as 23.1% but closed a l.....»»

Category: worldSource: nytJul 9th, 2018

Biotech ETFs Climb on Biogen’s Promising Clinical Trial

This article was originally published on ETFTrends.com......»»

Category: topSource: foxnewsJul 6th, 2018

Krystal Biotech: Data Due Year-End

Krystal Biotech: Data Due Year-End.....»»

Category: topSource: seekingalphaJul 5th, 2018

Compugen shares surge 12% premarket after FDA lifts clinical hold on cancer treatment

Compugen Ltd. shares climbed 12% in premarket trade Monday, after the Israeli biotech said the U.S. Foo.....»»

Category: topSource: marketwatchJul 2nd, 2018

Boulder biotech"s melanoma treatment gets FDA approval

A Boulder biotech's combination treatment for a form of skin cancer was approved this week by the U.S. Food and Drug Administration. Array BioPharma Inc. (Nasdaq: ARRY) said its Braftovi capsules in combination with Mektovi tablets has been approved .....»»

Category: topSource: bizjournalsJun 29th, 2018

Competing with WebMD and Everyday Health, new site focuses exclusively on cancer information

The competitive field of consumer health information has a new player. SurvivorNet, a website founded by a media veteran and a longtime biotech investor, officially launched today to provide... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkJun 27th, 2018

Short Sellers Run for Cover From Major Biotechs

The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased......»»

Category: blogSource: 247wallstJun 27th, 2018

3 Things In Biotech, June 21: Regeneron Sneaks Up In The Kidney Cancer Space

3 Things In Biotech, June 21: Regeneron Sneaks Up In The Kidney Cancer Space.....»»

Category: topSource: seekingalphaJun 22nd, 2018

Former Puma Biotech executive gets U.S. prison term for insider trading

BOSTON (Reuters) - A former Puma Biotechnology Inc executive was sentenced on Wednesday to 2-1/4 years in prison for trading on inside information ahead of announcements by the biopharmaceutical company about a breast cancer drug it was developing......»»

Category: topSource: reutersJun 20th, 2018

Biotech Stock Roundup: SRPT & SLDB Soar on Positive Data, ANIK & ZIOP Crash

Zacks.....»»

Category: topSource: redinewsJun 20th, 2018

Brainstorm Health: Sarepta Duchenne Therapy, CVS Drug Delivery, Trump’s New Obamacare Move

Brainstorm Health Daily: June 19, 2018 Hello, readers--This is Sy. Shares of biotech Sarepta Therapeutics shot off to the moon Tuesday after the company announced early data on its experimental gene therapy to treat .....»»

Category: europeSource: fortuneJun 19th, 2018

Fortress Biotech announces publication of CNDO-109-activated allogeneic NK data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

Pharma giant Roche just made a $2.4 billion bet on cancer data (FMI)

Reuters Roche on Tuesday bought the rest of Foundation Medicine, a company that collects genetic data from samples of cancer tissue or blood, for $2.4 billion. Roche .....»»

Category: topSource: businessinsiderJun 19th, 2018